We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Richard Link MD, PhD

Richard E Link MD, PhD

Carlton-Smith Endowed Chair in Urologic Education; Director, Division of Endourology and Minimally Invasive Surgery; Associate Professor, Scott Department of Urology; Baylor College of Medicine, Houston, Texas

Richard E. Link, M.D., Ph.D., Associate Professor, is a Board-certified and fellowship-trained urologist specializing in the treatment of urologic disease affecting the kidney, ureter, and prostate. He holds the Carlton-Smith Endowed Chair in Urologic Education at the Baylor College of Medicine (BCM), in Houston, Texas. He focuses on the use of laparoscopic, robotic-assisted, percutaneous, and endoscopic techniques to treat kidney tumors, renal and ureteral obstruction, and urinary tract stones. He directs the BCM Division of Endourology and Minimally Invasive Surgery and is active, nationally, in teaching these techniques to other urologists through the American Urological Association Office of Education. He has also directed the BCM fellowship program in Minimally Invasive Urologic Surgery since 2008. Dr. Link has been an early pioneer in the development of laparoendoscopic single-site donor nephrectomy, a less invasive laparoscopic technique in which a donor kidney can be removed via only a single, small periumbilical incision for transplantation. He serves as Director of Living Donor Procurement for several major kidney transplant programs in Houston. He also co-directs the BCM Comprehensive Stone Clinic, which provides a state-of-the-art multidisciplinary tertiary referral center for patients with complex kidney stones.

Dr. Link completed his Ph.D. in Molecular and Cellular Physiology at Stanford University, in the laboratory of Nobel Laureate Brian Kobilka. His research laboratory studies the genetic basis for renal cell carcinoma and urinary tract stone disease using a combination of genetically engineered mouse models, stem cell biology, and sophisticated whole genome molecular techniques. His clinical research interests include surgical simulation, decision analysis modeling, and the application of 3D reconstruction and printing techniques to surgical education.


Dr. Link's primary industry connection is through Boston Scientific where he serves as a consultant and on their medical education advisory board. That relationship is almost entirely related to stone management which is not the topic of this research, but I can provide additional disclosure details as needed.